EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ferrostatin-1 inhibits fibroblast fibrosis in keloid by inhibiting ferroptosis

Liu Yang, Xiuli Li, Yanli Wang

PeerJ · 14.06.2024 · 12 · e17551

DOI: 10.7717/peerj.17551 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, online erschienen am 14.06.2024. Verfasst von Liu Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Plastic & Cosmetics Surgery Department, Zibo Central Hospital, Zibo, China. Hauptthemen laut MEDLINE: Cyclohexylamines, Ferroptosis, Fibroblasts, Fibrosis. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Keloid is a chronic proliferative fibrotic disease caused by abnormal fibroblasts proliferation and excessive extracellular matrix (ECM) production. Numerous fibrotic disorders are significantly influenced by ferroptosis, and targeting ferroptosis can effectively mitigate fibrosis development. This study aimed to investigate the role and mechanism of ferroptosis in keloid development.

Methods

Keloid tissues from keloid patients and normal skin tissues from healthy controls were collected. Iron content, lipid peroxidation (LPO) level, and the mRNA and protein expression of ferroptosis-related genes including solute carrier family 7 member 11 (SLC7A11), glutathione peroxidase 4 (GPX4), transferrin receptor (TFRC), and nuclear factor erythroid 2-related factor 2 (Nrf2) were determined. Mitochondrial morphology was observed using transmission electron microscopy (TEM). Keloid fibroblasts (KFs) were isolated from keloid tissues, and treated with ferroptosis inhibitor ferrostatin-1 (fer-1) or ferroptosis activator erastin. Iron content, ferroptosis-related marker levels, LPO level, mitochondrial membrane potential, ATP content, and mitochondrial morphology in KFs were detected. Furthermore, the protein levels of α-smooth muscle actin (α-SMA), collagen I, and collagen III were measured to investigate whether ferroptosis affect fibrosis in KFs.

Results

We found that iron content and LPO level were substantially elevated in keloid tissues and KFs. SLC7A11, GPX4, and Nrf2 were downregulated and TFRC was upregulated in keloid tissues and KFs. Mitochondria in keloid tissues and KFs exhibited ferroptosis-related pathology. Fer-1 treatment reduced iron content, restrained ferroptosis and mitochondrial dysfunction in KFs, Moreover, ferrostatin-1 restrained the protein expression of α-SMA, collagen I, and collagen III in KFs. Whereas erastin treatment showed the opposite results.

Conclusion

Ferroptosis exists in keloid. Ferrostatin-1 restrained ECM deposition and fibrosis in keloid through inhibiting ferroptosis, and erastin induced ECM deposition and fibrosis through intensifying ferroptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclohexylaminesFerroptosisFibroblastsFibrosisKeloidAdultFemaleHumansMaleActinsAmino Acid Transport System y+IronLipid PeroxidationMembrane Potential, MitochondrialMitochondriaNF-E2-Related Factor 2PhenylenediaminesPhospholipid Hydroperoxide Glutathione PeroxidasePiperazinesReceptors, Transferrin

Stichwörter der Autor:innen

ErastinFerroptosisFerrostatin-1FibroblastsFibrosisKeloid

Substanzen

ActinsAmino Acid Transport System y+Cyclohexylamineserastinferrostatin-1IronNF-E2-Related Factor 2NFE2L2 protein, humanPhenylenediaminesPhospholipid Hydroperoxide Glutathione Peroxidase

Autor:innen und Institutionen

  • Plastic & Cosmetics Surgery Department, Zibo Central Hospital, Zibo, China.

Zitieren

APA

Yang, L., Li, X., & Wang, Y. (2024). Ferrostatin-1 inhibits fibroblast fibrosis in keloid by inhibiting ferroptosis. PeerJ, 12, e17551. https://doi.org/10.7717/peerj.17551

Vancouver

Yang L, Li X, Wang Y. Ferrostatin-1 inhibits fibroblast fibrosis in keloid by inhibiting ferroptosis. PeerJ. 2024;12:e17551. doi:10.7717/peerj.17551

BibTeX
@article{Yang2024,
  author = {Yang, Liu and Li, Xiuli and Wang, Yanli},
  title = {Ferrostatin-1 inhibits fibroblast fibrosis in keloid by inhibiting ferroptosis},
  journal = {PeerJ},
  year = {2024},
  volume = {12},
  pages = {e17551},
  doi = {10.7717/peerj.17551}
}
Kostenlos starten →